Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free NAMSW Stock Alerts

NewAmsterdam Pharma (NAMSW) Competitors

NewAmsterdam Pharma logo
$27.31 -2.68 (-8.94%)
As of 05/14/2026 03:30 PM Eastern
Compare

NAMSW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy NewAmsterdam Pharma stock or one of its competitors? MarketBeat compares NewAmsterdam Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NewAmsterdam Pharma include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does NewAmsterdam Pharma compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than NewAmsterdam Pharma. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for NewAmsterdam Pharma. NewAmsterdam Pharma's average media sentiment score of 1.87 beat 60 Degrees Pharmaceuticals' score of 0.44 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
NewAmsterdam Pharma Very Positive

Summary

NewAmsterdam Pharma beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Alpha Tau Medical?

NewAmsterdam Pharma (NASDAQ:NAMSW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
NewAmsterdam PharmaN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than NewAmsterdam Pharma. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for NewAmsterdam Pharma. NewAmsterdam Pharma's average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.19 indicating that NewAmsterdam Pharma is being referred to more favorably in the media.

Company Overall Sentiment
NewAmsterdam Pharma Very Positive
Alpha Tau Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

NewAmsterdam Pharma beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Apollomics?

Apollomics (NASDAQ:APLMW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 beat NewAmsterdam Pharma's score of 1.87 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
NewAmsterdam Pharma Very Positive

Summary

Apollomics and NewAmsterdam Pharma tied by winning 1 of the 2 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to BioVie?

BioVie (NASDAQ:BIVIW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

In the previous week, BioVie and BioVie both had 1 articles in the media. BioVie's average media sentiment score of 1.87 equaled NewAmsterdam Pharma'saverage media sentiment score.

Company Overall Sentiment
BioVie Very Positive
NewAmsterdam Pharma Very Positive

Summary

NewAmsterdam Pharma beats BioVie on 1 of the 1 factors compared between the two stocks.

How does NewAmsterdam Pharma compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and NewAmsterdam Pharma (NASDAQ:NAMSW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.83KN/AN/AN/AN/A
NewAmsterdam Pharma$22.57MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
NewAmsterdam Pharma N/A N/A N/A

In the previous week, Cardio Diagnostics had 1 more articles in the media than NewAmsterdam Pharma. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for NewAmsterdam Pharma. NewAmsterdam Pharma's average media sentiment score of 1.87 beat Cardio Diagnostics' score of 0.43 indicating that NewAmsterdam Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Cardio Diagnostics Neutral
NewAmsterdam Pharma Very Positive

Summary

NewAmsterdam Pharma beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

Get NewAmsterdam Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAMSW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAMSW vs. The Competition

Export
MetricNewAmsterdam PharmaBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$459.75M$6.34B$12.37B
Dividend YieldN/A3.86%2.80%5.35%
P/E RatioN/A3.8320.6625.63
Price / SalesN/A7,689.82544.2776.59
Price / CashN/A13.1343.2656.33
Price / BookN/A82.949.876.97
Net IncomeN/A-$96.07M$3.55B$333.62M
7 Day Performance-1.37%1.13%1.67%1.09%
1 Month Performance13.63%0.41%0.46%3.08%
1 Year Performance216.45%69.07%39.37%35.68%

NewAmsterdam Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAMSW
NewAmsterdam Pharma
N/A$27.31
-8.9%		N/A+212.5%$0.00$22.57MN/A29
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-0.4%		N/A-13.3%$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$0.99
-8.3%		N/A+778.9%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-13.0%		N/A+37.8%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.32
-8.5%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NAMSW) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel